Stoneridge Investment Partners »

Rigel Pharmaceuticals shares owned by Stoneridge Investment Partners

Quarter-by-quarter ownership of Rigel Pharmaceuticals (RIGL) shares owned by Stoneridge Investment Partners from 13F filings

Historical chart of Stoneridge Investment Partners investment in Rigel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rigel Pharmaceuticals held by Stoneridge Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rigel Pharmaceuticals by Stoneridge Investment Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $46k 31k 1.47

More positions owned by Stoneridge Investment Partners

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Alphabet Inc Class C cs (GOOG)
Pfizer (PFE)
Biogen Idec (BIIB)
General Motors Company (GM)
Deere & Company (DE)
Adobe Systems Incorporated (ADBE)
Visa (V)
Humana (HUM)
PNC Financial Services (PNC)
Nike (NKE)

View all positions for Stoneridge Investment Partners

Top funds holding Rigel Pharmaceuticals

Armistice Capital
BlackRock
Morgan Stanley
Vanguard Group
Soleus Capital Management
Acadian Asset Management
Geode Capital Management
Nuveen Asset Management
Jacobs Levy Equity Management
CM Management
Assenagon Asset Management
Millennium Management
Ing Investment Management
Northern Trust
GSA Capital Partners

View all funds holding Rigel Pharmaceuticals